<SEC-DOCUMENT>0001140361-16-078067-index.html : 20160829 <SEC-HEADER>0001140361-16-078067.hdr.sgml : 20160829 <ACCEPTANCE-DATETIME>20160829163131 ACCESSION NUMBER: 0001140361-16-078067 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20160829 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160829 DATE AS OF CHANGE: 20160829 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoCyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 161858180 BUSINESS ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY STREET 2: SUITE 100 CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 510-521-3390 MAIL ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY STREET 2: SUITE 100 CITY: ALAMEDA STATE: CA ZIP: 94502 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>form8k.htm <DESCRIPTION>ONCOCYTE CORPORATION 8-K 8-29-2016 <TEXT> Document 1 - file: form8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>ex4_1.htm <DESCRIPTION>EXHIBIT 4.1 <TEXT> Document 2 - file: ex4_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>ex10_1.htm <DESCRIPTION>EXHIBIT 10.1 <TEXT> Document 3 - file: ex10_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>4 <FILENAME>ex10_2.htm <DESCRIPTION>EXHIBIT 10.2 <TEXT> Document 4 - file: ex10_2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>5 <FILENAME>ex99_1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 5 - file: ex99_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image00002.jpg <TEXT> Document 6 - file: image00002.jpg
</DOCUMENT> </SEC-DOCUMENT>